FDA Approved: FOLOTYN — Original Application (Acrotech Biopharma Inc)

View source ↗

Summary

FDA approved Folotyn (pralatrexate) as an initial approval for relapsed or refractory peripheral T-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• Folotyn (pralatrexate)

Snippet

ORIG AP for FOLOTYN (PRALATREXATE)